Editorial: Measurable residual disease in hematologic malignancies

Frontiers in Oncology

Oncology

Francesco Buccisano¹  Raffaele Palmieri¹  Sara Galimberti²  Monica L. Guzman³ 

[1] Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy;Division of Hematology, University Hospital of Pisa, Pisa, Italy;Weill Cornell Medicine, Cornell University, White Plains, NY, United States;

关键词: MRD - measurable residual disease;    multiparameter flow cytometry;    polymerase chain reaction;    surrogate endpoint biomarker;    next generation sequencing;    next generation flow cytometry (NGF);    chimerism after allo-HSCT;   

DOI  :  10.3389/fonc.2023.1204393

 received in 2023-04-12, accepted in 2023-04-27,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Buccisano, Palmieri, Guzman and Galimberti